clonidine has been researched along with arachidonylcyclopropylamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebrahimi-Ghiri, M; Nasehi, M; Zamanparvar, M; Zarrindast, MR | 1 |
| Beiranvand, A; Moghaddasi, M; Nasehi, M; Zarrindast, MR | 1 |
2 other study(ies) available for clonidine and arachidonylcyclopropylamide
| Article | Year |
|---|---|
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Amygdala; Animals; Arachidonic Acids; Auditory Perception; Basolateral Nuclear Complex; Cannabinoid Receptor Agonists; Clonidine; Conditioning, Psychological; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Male; Memory; Mice; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Yohimbine | 2016 |
Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB1 receptor agonist, in rats; possible involvement of Ca2+ channels.
Topics: Amnesia; Animals; Arachidonic Acids; Calcium Channels; Clonidine; Dose-Response Relationship, Drug; Imidazoles; Male; Memory; Memory Disorders; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Yohimbine | 2016 |